2.5 tirzepatide in syringe Mounjaro (Tirzepatide) Injection 7.5 mg/0.5 mL Syringes Zeptide Injection Prefilled Syringe -

GLP1 GLP1 GLP1 GLP1 GLP1 GLP1

It does not increase insulin

Switching patients to a different medication sounds simple, but a research review in the American Journal of Therapeutics found that the consequences of switching a brand-name medication to a generic include: Decreased medication adherence Poorer clinical outcomes (e.g., symptom relief and overall health) An increase in adverse clinical outcomes, such as hospitalization and even death Ultimately, an Ozempic shortage increases the risk of harm to Type 2 diabetes patients who need this drug

While its similar to other GLP-1s like Ozempic (semaglutide) and Trulicity (dulaglutide), Mounjaro mimics a second hormone along with the glucagon-like peptide-1 (GLP-1): GIP, which stands for glucose-dependent insulinotropic polypeptide